SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 241,407.76 |
Enterprise Value ($M) | 297,186.76 |
Book Value ($M) | 17,287.00 |
Book Value / Share | 9.80 |
Price / Book | 13.96 |
NCAV ($M) | -94,753.00 |
NCAV / Share | -53.71 |
Price / NCAV | -2.55 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.09 |
Return on Assets (ROA) | 0.05 |
Return on Equity (ROE) | 0.49 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.82 |
Current Ratio | 0.96 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 26,488.00 |
Assets | 134,544.00 |
Liabilities | 121,241.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 58,054.00 |
Operating Income | 22,671.00 |
Net Income | 11,836.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 24,943.00 |
Cash from Investing | -623.00 |
Cash from Financing | -24,803.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | BlackRock Inc. | 7.80 | 8.19 | |
13G/A | Vanguard Group Inc | 8.95 | 8.21 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
697,915 | 6,661,613 | 10.48 | |
1,316,144 | 11,895,561 | 11.06 | |
692,007 | 12,579,059 | 5.50 | |
675,069 | 7,671,512 | 8.80 | |
(click for more detail) |
Similar Companies | |
---|---|
ABT – Abbott Laboratories | ADCT – Adc Therapeutics SA |
Financial data and stock pages provided by
Fintel.io